Insys Therapeutics, Inc. (INSY) [Rocket]

In millions, except per share items	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	S-1/A
Assets
Cash and equivalents	31.6	32.0	104.6	79.5	58.1	45.4	0.4	0.0
Short-term investments	64.1	85.2	78.2	79.6	24.8
Accounts receivable, net	12.6	21.5	20.7	47.3	26.5	16.3	3.1
Inventories	8.6	17.4	20.4	41.7	34.8	14.5	7.1	6.7
Other current assets	9.4	19.8	5.7	4.0	2.2	5.9	1.3	1.2
Total current assets	126.3	175.9	229.6	252.1	146.4	82.2	11.9	7.9
Property, plant, and equipment, net	52.1	55.2	43.2	38.4	29.9	10.1	6.8	7.5
Intangibles								5.3
Goodwill								0.1
Long-term investments	8.4	46.7	53.8	43.2	23.3
Other fixed assets	5.7	1.2	6.3	0.0	3.3	0.0	0.1	0.2
Total assets	192.5	279.1	356.1	351.3	215.1	100.6	18.7	21.0

Accrued expenses	47.8	159.3	22.3	19.8	6.9	3.6	1.4	0.5
Short-term debt	0.0	0.0	0.0	0.0	0.0	0.0	70.2	0.0
Short-term debt							70.2
Deferred revenues							3.8
Other current liabilities	59.0	47.8	56.3	70.6	38.8	17.5	8.0	61.2
Total current liabilities	106.9	207.2	78.6	90.4	45.7	21.1	83.4	61.7
Other liabilities	128.8	5.7	7.9	8.5	3.8			2.5
Total liabilities	235.6	212.9	86.5	99.0	49.5	21.1	83.4	64.2

Shareholders' equity [+]	-43.1	66.2	269.6	252.3	165.7	79.5	-64.7	-43.2
Paid-in capital	292.5	278.4	256.5	246.7	216.1	168.2	64.6	61.7
Retained earnings	-336.1	-212.4	12.7	5.1	-51.1	-89.0	-129.4	-105.0
Treasury stock	32.6	32.6	32.6
Tangible shareholders' equity	-43.1	66.2	269.6	252.3	165.7	79.5	-64.7	-48.6